Covington Goes to Boston, as More Big Pharma Clients Relocate to City

Doug Gibson was quoted by The National Law Journal in an article highlighting Megan Gates's arrival concurrent with Covington's new Boston office opening this spring with broad-based life sciences capabilities.

“We have seen more and more of our Big Pharma clients relocating operations to Boston,” Doug said. “That combined with just the level of expertise out of the great universities in Boston has also created sort of, more of a biotech and emerging company hub for life sciences. So when you combine those two factors, it’s a more and more important market for life sciences.”

Doug noted that European life sciences clients at the firm’s London office have also identified Boston as a potential area for expansion for those looking to go public in the U.S.

“We’ve been thinking about opening in Boston for a while,” Doug said. “The core play for us is in the life sciences area because that’s a very significant practice area for us.”